Journals / Türk Biyokimya Dergisi / 2014 / Cilt: 39 - Sayı: 4

The effects of dexmedetomidine on oxidant - antioxidant systems in the experimental model of carbondioxide pneumoperitoneum

[Deneysel karbondioksit pnömoperitonyum modelinde deksmedetomidin'in oksidan-antioksidan sistem üzerine etkisinin araştırılması]

Pages
488–494
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The rats were rested 30 minutes after desufflation and blood samples were obtained for; ischaemia modified albumin (IMA), myeloperoxidase (MPO), advanced oxidation protein products (AOPP), catalase (CAT), paraoxonase (PON1) and platelet-activating factor acetylhydrolase (PAF-AH) analyses.Results: When compared with the control group; the serum IMA levels significantly decreased in group II, and also increased in group III as compared to control (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study was to investigate the changes of oxidative and anti-oxidative systems in the splanchnic area during carbon dioxide pneumoperitoneum and to determine whether the administration of dexmedetomidine has effects on these systems.Methods: Forty rats were randomized into four groups: Group I; Control, Group II; No pneumoperitoneum, Dexmedetomidine administration, Group III; Pneumoperitoneum, no Dexmedetomidine administration and Group IV; Pneumoperitoneum and Dexmedetomidine administration 30 minutes before insufflation.
📊
Key Findings & Data:Objective: The aim of the study was to investigate the changes of oxidative and anti-oxidative systems in the splanchnic area during carbon dioxide pneumoperitoneum and to determine whether the administration of dexmedetomidine has effects on these systems.Methods: Forty rats were randomized into four groups: Group I; Control, Group II; No pneumoperitoneum, Dexmedetomidine administration, Group III; Pneumoperitoneum, no Dexmedetomidine administration and Group IV; Pneumoperitoneum and Dexmedetomidine administration 30 minutes before insufflation.
💡
Conclusion & Impact:The rats were rested 30 minutes after desufflation and blood samples were obtained for; ischaemia modified albumin (IMA), myeloperoxidase (MPO), advanced oxidation protein products (AOPP), catalase (CAT), paraoxonase (PON1) and platelet-activating factor acetylhydrolase (PAF-AH) analyses.Results: When compared with the control group; the serum IMA levels significantly decreased in group II, and also increased in group III as compared to control (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the study was to investigate the changes of oxidative and anti-oxidative systems in the splanchnic area during carbon dioxide pneumoperitoneum and to determine whether the administration of dexmedetomidine has effects on these systems.Methods: Forty rats were randomized into four groups: Group I; Control, Group II; No pneumoperitoneum, Dexmedetomidine administration, Group III; Pneumoperitoneum, no Dexmedetomidine administration and Group IV; Pneumoperitoneum and Dexmedetomidine administration 30 minutes before insufflation. The rats were rested 30 minutes after desufflation and blood samples were obtained for; ischaemia modified albumin (IMA), myeloperoxidase (MPO), advanced oxidation protein products (AOPP), catalase (CAT), paraoxonase (PON1) and platelet-activating factor acetylhydrolase (PAF-AH) analyses.Results: When compared with the control group; the serum IMA levels significantly decreased in group II, and also increased in group III as compared to control (p

Özet

Amaç: Bu çalışmanın amacı, karbondioksit pnömoperitonyum sırasında splanknik sahada oluşan oksidan ve antioksidan sistemlerdeki değişiklikleri ve deksmedetomidin uygulamasının bu değişiklikler üzerine etki gösterip göstermediğini tespit etmektir.Metod: Kırk adet rat randomize olarak dört gruba ayrıldı. Grup I; kontrol, Group II; pnömoperitonyum uygulanmayan sadece deksmedetomidin verilen grup, Group III; pnömoperitonyum uygulanan ancak deksmedetomidin verilmeyen grup ve Grup IV; pnömoperitonyum uygulanan ve insuflasyondan 30 dakika önce deksmedetomidin verilen grup. Desuflasyon sonrası 30 dakika dinlendirilen ratlardan; iskemi modifiye albümin (İMA), miyeloperoksidaz (MPO), ileri oksidasyon protein ürünleri (AOPP), katalaz (CAT), paroksonaz (PON1) ve trombosit aktive edici faktör asetil hidrolaz (PAF-AH) analizi için kardiyak ponksiyonla kan örnekleri alındı.Bulgular: Kontrol grubu ile karşılaştırıldığında, serum İMA seviyeleri Grup II'de azalmış Grup III'de ise artmış olarak bulundu (p

🔖

Cite This Article

YAĞAN, Ö., BAYRAK, T., TAŞ, N., BAYRAK, A., NOYAN, T., AYYILDIZ, S. N., KARAKAHYA, M., ÜSTÜN, B., IŞIK, S. (2022). The effects of dexmedetomidine on oxidant - antioxidant systems in the experimental model of carbondioxide pneumoperitoneum. Türk Biyokimya Dergisi, Cilt: 39 - Sayı: 4, 488–494. https://ajindex.com/articles/621167

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Glantzounis GK, Tselepis AD, Tambaki AP, Trikalinos TA, Manataki AD, et al. Laparoscopic surgery-induced changes in oxidative stress markers in human plasma. Surg Endosc 2001; 15(11):1315- 9
  2. Cay A, Imamoglu M, Unsal MA, Aydin S, Alver A, et al. Does anti-oxidant prophylaxis with melatonin prevent adverse outcomes related to increased oxidative stress caused by laparoscopy in experimental rat model? J Surg Res 2006; 135(1):2-8
  3. Bukan MH, Bukan N, Kaymakcioglu N, Tufan T. Effects of open vs. laparoscopic cholecystectomy on oxidative stress. Tohoku J Exp Med 2004; 202(1):51-6
  4. Nunes RR, Nora FS, Dumaresq DM, Cavalcante RM, Costa AA, et al. Influence of total intravenous anesthesia, entropy and laparoscopy on oxidative stress. Rev Bras Anestesiol 2012; 62(4):484- 501
  5. Yağmurdur H, Başar H. Ekstremite cerrahisinde turnike uygulamasına bağlı iskemi-reperfüzyon hasarı ve anestezik yaklaşım. TOTBİD Dergisi 2007; 6(1-2);30-5
  6. Gul M, Kayhan B, Elbe H, Dogan Z, Otlu A. Histological and Biochemical Effects of Dexmedetomidine on Liver during an Inflammatory Bowel Disease. Ultrastruct Pathol 2013 Oct 17. [Epub ahead of print] [7] Uysal HY, Cuzdan SS, Kayıran O, Basar H, Fidancı V, et al. Preventive effect of dexmedetomidine in ischemia-reperfusion injury. J Craniofac Surg 2012; 23(5):1287-91
  7. Tufek A, Tokgoz O, Aliosmanoglu I, Alabalık U, Evliyaoglu O, et al. The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats. Int J Surg 2013; 11(1):96-100
  8. Geze S, Cekic B, Imamoglu M, Yörük MF, Yulug E, et al. Use of dexmedetomidine to prevent pulmonary injury after pneumoperitoneum in ventilated rats. Surg Laparosc Endosc Percutan Tech 2012; 22(5):447-53
  9. Qiao H, Sanders RD, Ma D, Wu X, Maze M. Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care 2009; 13(4):R136
  10. Sezer A, Memiş D, Usta U, Süt N. The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study. Ulus Travma Acil Cerrahi Derg 2010; 16(2):108-12
  11. Unal E, Eris C, Kaya B, Uzun H, Cavdar F, et al. Paraoxonase and arylesterase activities, lipid profile, and oxidative damage in experimental ischemic colitis model. Gastroenterol Res Pract 2012; 2012:979506
  12. Omür D, Hacivelioglu SÖ, Oguzalp H, Uyan B, Kiraz HA, et al. The effect of anaesthesia technique on maternal and cord blood ischaemia-modified albumin levels during caesarean secti